Answers are grounded in this paper and cite their sources.
HIV-1 replication has been inhibited by using a compound able to target the human cellular cofactor DEAD-box ATPase DDX3, essential for HIV-1 RNA nuclear export. This compound, identified by means of a computational protocol based on pharmacophoric modeling and molecular docking calculations, represents the first small molecule with such a mechanism of action and could lay the foundations for a pioneering approach for the treatment of HIV-1 infections.
No takes yet. Share an insight, caveat, or question.
Maga et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: